0001209191-20-029928.txt : 20200518 0001209191-20-029928.hdr.sgml : 20200518 20200518082815 ACCESSION NUMBER: 0001209191-20-029928 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200515 FILED AS OF DATE: 20200518 DATE AS OF CHANGE: 20200518 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MIDDLEKAUFF W BRADFORD CENTRAL INDEX KEY: 0001214501 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38906 FILM NUMBER: 20888117 MAIL ADDRESS: STREET 1: 200 CONNELL DRIVE STREET 2: SUITE 1600 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Immunovant, Inc. CENTRAL INDEX KEY: 0001764013 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 832771572 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 320 WEST 37TH STREET CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: 917-580-3099 MAIL ADDRESS: STREET 1: 320 WEST 37TH STREET CITY: NEW YORK STATE: NY ZIP: 10018 FORMER COMPANY: FORMER CONFORMED NAME: Health Sciences Acquisitions Corp DATE OF NAME CHANGE: 20190108 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-05-15 0 0001764013 Immunovant, Inc. IMVT 0001214501 MIDDLEKAUFF W BRADFORD 320 W 37TH STREET, 3RD FLOOR NEW YORK NY 10018 0 1 0 0 General Counsel Stock Option (right to buy) 19.01 2020-05-15 4 A 0 142600 0.00 A 2030-05-14 Common Stock 142600 142600 D 25% of the shares underlying the option vests on the first anniversary of the grant date, and the remainder vests in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. /s/ W. Bradford Middlekauff 2020-05-18